🧬 Confirmed: Myeloma-Positive Samples Identified

We are excited to share that our testing team has successfully identified IgA Myeloma, IgM Myeloma, and IgG Myeloma samples, further demonstrating the clinical relevance and performance of our solution.

✅ Positive identification of diverse myeloma markers reinforces the importance of early and accurate detection
🧪 Designed for high sensitivity and specificity in routine diagnostic workflows

In the fight against multiple myeloma, every sample counts. Our solution provides the clarity labs need to deliver timely, informed decisions for better patient outcomes.

Precision starts here.